Literature DB >> 24243711

Validity of smoking prevalence estimates from primary care electronic health records compared with national population survey data for England, 2007 to 2011.

Helen P Booth, A Toby Prevost, Martin C Gulliford.   

Abstract

PURPOSE: Primary care electronic health records (EHRs) are increasingly used as a resource for epidemiological research. Cigarette smoking is an important variable in many epidemiological studies. We evaluated the validity of smoking records in primary care EHRs by comparing estimates for smoking prevalence from primary care EHRs with national health survey data.
METHODS: Data were analysed for adults over 30 years of age from the Clinical Practice Research Datalink (CPRD) in comparison with data from the Health Survey for England between 2007 and 2011. Electronic health records in the CPRD were searched for records of smoking status and smoking cessation treatment. Annual age- and sex-standardised prevalence of current-, non- and former smoking were calculated, and compared with equivalent data from the Health Survey for England (HSE).
RESULTS: The difference between estimates of current smoking in CPRD and HSE was generally <1% from 2007 to 2011. In 2011, the prevalence of current smoking in men was: CPRD 24.3%, HSE 24.2%. The mean difference was 0.1% (95% confidence interval −1.5 to 1.7%). In women, current smoking prevalence was CPRD 20.3%, HSE 19.0%; mean difference 1.3% (0.0 to 2.6%). Estimates for former smoking were lower in CPRD than HSE for men (CPRD 26.7%, HSE 31.3%) and women (CPRD 22.9%, HSE 25.0%).
CONCLUSIONS: Prevalence estimates for current smoking, and non-smoking, from primary care EHRs are similar to those from nationally representative surveys, but former smoking may be under-recorded.
© 2013 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 24243711     DOI: 10.1002/pds.3537

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  32 in total

1.  Capture of tobacco use among population-based registries: Findings from 10 National Program of Cancer Registries states.

Authors:  David A Siegel; S Jane Henley; Jennifer M Wike; A Blythe Ryerson; Christopher J Johnson; Judy R Rees; Lori A Pollack
Journal:  Cancer       Date:  2018-03-26       Impact factor: 6.860

2.  Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink.

Authors:  Parisa Karimi; Brenda M Birmann; Lesley A Anderson; Charlene M McShane; Shahinaz M Gadalla; Joshua N Sampson; Sam M Mbulaiteye
Journal:  Br J Haematol       Date:  2018-04-20       Impact factor: 6.998

3.  Smoking cessation interventions for patients with coronary heart disease and comorbidities: an observational cross-sectional study in primary care.

Authors:  David N Blane; Daniel Mackay; Bruce Guthrie; Stewart W Mercer
Journal:  Br J Gen Pract       Date:  2016-12-05       Impact factor: 5.386

4.  Contributions of increasing obesity and diabetes to slowing decline in subclinical coronary artery disease.

Authors:  Carin Y Smith; Kent R Bailey; Jane A Emerson; Peter N Nemetz; Véronique L Roger; Pasquale J Palumbo; William D Edwards; Cynthia L Leibson
Journal:  J Am Heart Assoc       Date:  2015-04-22       Impact factor: 5.501

5.  The relationship between prior antimicrobial prescription and meningitis: a case-control study.

Authors:  David Armstrong; Mark Ashworth; Alex Dregan; Patrick White
Journal:  Br J Gen Pract       Date:  2016-03-10       Impact factor: 5.386

6.  Systolic Blood Pressure Trajectory, Frailty, and All-Cause Mortality >80 Years of Age: Cohort Study Using Electronic Health Records.

Authors:  Rathi Ravindrarajah; Nisha C Hazra; Shota Hamada; Judith Charlton; Stephen H D Jackson; Alex Dregan; Martin C Gulliford
Journal:  Circulation       Date:  2017-04-21       Impact factor: 29.690

7.  Generalizing Randomized Clinical Trial Results: Implementation and Challenges Related to Missing Data in the Target Population.

Authors:  Jin-Liern Hong; Michele Jonsson Funk; Robert LoCasale; Sara E Dempster; Stephen R Cole; Michael Webster-Clark; Jessie K Edwards; Til Stürmer
Journal:  Am J Epidemiol       Date:  2018-04-01       Impact factor: 4.897

8.  Characterizing Adults Receiving Primary Medical Care in New York City: Implications for Using Electronic Health Records for Chronic Disease Surveillance.

Authors:  Matthew L Romo; Pui Ying Chan; Elizabeth Lurie-Moroni; Sharon E Perlman; Remle Newton-Dame; Lorna E Thorpe; Katharine H McVeigh
Journal:  Prev Chronic Dis       Date:  2016-04-28       Impact factor: 2.830

9.  What are the effects of varenicline compared with nicotine replacement therapy on long-term smoking cessation and clinically important outcomes? Protocol for a prospective cohort study.

Authors:  Neil M Davies; Gemma Taylor; Amy E Taylor; Kyla H Thomas; Frank Windmeijer; Richard M Martin; Marcus R Munafò
Journal:  BMJ Open       Date:  2015-11-05       Impact factor: 2.692

10.  Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case-cross-over study.

Authors:  Kyla H Thomas; Neil M Davies; Amy E Taylor; Gemma M J Taylor; David Gunnell; Richard M Martin; Ian Douglas
Journal:  Addiction       Date:  2020-12-14       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.